Ocuphire Pharma (OCUP) Acquires Opus Genetics Oct 22, 2024 04:05PM
Ocuphire Pharma (OCUP) Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% Sep 30, 2024 08:01AM
Ocuphire Pharma (OCUP) Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia Sep 5, 2024 08:08AM
Ocuphire (OCUP) PT Lowered to $18 at H.C. Wainwright Aug 14, 2024 06:43AM
Ocuphire Pharma, Inc. (OCUP) Misses Q2 EPS by 6c Aug 13, 2024 08:25AM


Jul 10, 2024 08:05AM Ocuphire Pharma (OCUP) to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July